Nisa Investment Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.4K | Hold |
|
|||||
|
2025
Q2 | $25.3K | Buy |
|
|||||
|
2025
Q1 | $20.9K | Buy |
|
|||||
|
2024
Q4 | $18.8K | Sell |
|
|||||
|
2024
Q3 | $19.5K | Buy |
|
|||||
|
2024
Q2 | $12.9K | Buy |
|
|||||
|
2024
Q1 | $10.6K | Buy |
|
|||||
|
2023
Q4 | $11.4K | Sell |
|
|||||
|
2023
Q3 | $37.7K | Buy |
|
|||||
|
2023
Q2 | $37.2K | Buy |
|
|||||
|
2023
Q1 | $16K | Sell |
|
|||||
|
2022
Q4 | $73K | Buy |
|
|||||
|
2022
Q3 | $85K | Buy |
|
|||||
|
2022
Q2 | $66K | Hold |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $107K | Sell |
|
|||||
|
2021
Q3 | $165 | Hold |
|
|||||
|
2021
Q2 | $182 | Sell |
|
|||||
|
2021
Q1 | $121 | Buy |
|
|||||
|
2020
Q4 | $22K | Buy |
|
|||||
|
2020
Q3 | $7K | Hold |
|
|||||
|
2020
Q2 | $10K | Buy |
|
|||||
|
2020
Q1 | $4K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $8K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $7K | Buy |
|